patients hiv virus middle immunodeficiency says chemotherapy ravages immune system taking step late year spun concord California biopharmaceutical company testing approach making vaccines employ dead unable reproduce able stimulate immune system big worry cause listeriosis people weakened immune systems says tom dubensky anza co founder chief scientific officer live attenuated vaccines ability revert dangerous anza funding hoping approach animal testing develop vaccine hcv hiv anza testing second approach presently human clinical trials vaccine development uses form live weakened listeria modified not revert dangerous behavior company conducting u.s. food drug administration approved early stage clinical studies approach sites u.s. patients advanced